Astrana Health, INC 8-K filings

Astrana Health announced robust second quarter 2026 financial results, showcasing significant year-over-year growth in revenue, net income, and adjusted EBITDA, and raised its full-year adjusted EBITDA guidance.

Astrana Health announced its Accountable Care Organizations generated $120.4 million in gross shared savings for the 2024 performance year, with all eight ACOs achieving net shared savings.

Astrana Health, Inc. reported the retirement of its Chief Accounting Officer, Glenn Sobotka, effective August 7, 2026, with John Vong appointed as his successor.

Astrana Health stockholders approved the amended 2024 Equity Incentive Plan and re-elected nine directors at the 2026 Annual Meeting.

Astrana Health, Inc. reports the resignation of its Chief Medical Officer, Dinesh Kumar, M.D., effective June 1, 2026.

Astrana Health, Inc. has released an updated corporate presentation for use in investor meetings and conferences.

Astrana Health, Inc. has completed its $674.9 million acquisition of Prospect Health Plan and Alta Newport Hospital, significantly increasing its pro forma annual revenue to over $3.8 billion.

Astrana Health, Inc. updated its corporate investor presentation, highlighting strong financial results for 2025, robust growth projections for 2026, and strategic advancements in its value-based care model.

Astrana Health announced record revenue and adjusted EBITDA for 2025, alongside an increased share repurchase program, despite a delay in its 10-K filing due to an internal control weakness.

Astrana Health, Inc. updated its corporate presentation, reiterating its full-year 2025 financial guidance and highlighting its value-based care model and strategic growth pillars.

Astrana Health, Inc. announced solid third-quarter 2025 financial results, including 100% year-over-year revenue growth, while updating full-year guidance due to contract delays.

Astrana Health, Inc. completed the acquisition of Prospect Health Plan and Foothill Regional Medical Center for $678.2 million, significantly expanding its healthcare services while reporting a pro forma net loss for the latest quarter.

Astrana Health announced robust second quarter 2025 financial results, with total revenue increasing 35% to $654.8 million, and reiterated its full-year guidance.

Astrana Health, Inc. has successfully closed its acquisition of Prospect Health for a reduced purchase price of $707.9 million, updating its full-year 2025 revenue and adjusted EBITDA guidance to reflect the integration.

Astrana Health, Inc. announced that its stockholders approved an amended and restated 2024 Equity Incentive Plan, increasing shares reserved for issuance by 2 million, and re-elected its board of directors at the 2025 Annual Meeting.

Astrana Health, Inc. announced it has updated its corporate presentation for investor conferences and meetings, furnishing it as an exhibit to a current report on Form 8-K.

Astrana Health, Inc. released an updated corporate presentation on May 13, 2025, for use at upcoming conferences and meetings.

Astrana Health, Inc. announced a 53% increase in total revenue for the first quarter of 2025, driven by growth in its Care Partners segment and strategic acquisitions.

Astrana Health, Inc. announced the appointment of Glenn W. Sobotka as its new Chief Accounting Officer, effective March 26, 2025, replacing John Vong who will transition to a new role within the company.

Astrana Health updates its preliminary consolidated balance sheet for December 31, 2024, due to revisions related to the acquisition of certain entities, while maintaining its full-year 2025 guidance.

Astrana Health, Inc. updated its corporate presentation on March 10, 2025, outlining its strategy and financial outlook, including a potential acquisition of certain businesses and assets of Prospect Medical Holdings, Inc.

Astrana Health, Inc. updates its corporate presentation for use at upcoming conferences and meetings, as announced in a Form 8-K filing on March 3, 2025.

Astrana Health announces its fourth quarter and year-end 2024 financial results, highlighting significant revenue growth and strategic expansions.

Astrana Health, Inc. enters into a second amended and restated credit agreement providing a $1.3 billion credit facility to refinance debt, cover transaction costs, and fund acquisitions.

Astrana Health, Inc. has agreed to repurchase 300,000 shares of its common stock from Allied Physicians of California for approximately $10.6 million.

Astrana Health, Inc. confirms its ongoing acquisition of certain Prospect Medical Holdings, Inc. businesses and assets, which are unaffected by Prospect Medical's recent Chapter 11 bankruptcy filing.

Astrana Health, Inc. released an investor presentation containing financial information in preparation for upcoming conference presentations.

Astrana Health has granted special one-time equity awards to key members of its leadership team to promote retention and incentivize performance.

Astrana Health, Inc. has entered into an agreement to purchase assets from Prospect Medical Holdings for $745 million, backed by a $1.195 billion financing commitment.

Astrana Health has announced a definitive agreement to acquire certain businesses and assets of Prospect Health System for $745 million, significantly expanding its provider network and member base.